Postmenopausal women who participate in vigorous physical activity have a lower risk of total and hip fractures, but higher knee fracture risk, say researchers recently writing in JAMA Network Open.
Estrogen-based hormone therapy may not be associated with reduced loss of lean body mass compared with no hormone therapy in postmenopausal women, find researchers writing in JAMA Network Open last month.
Women who have primary Sjögren’s Syndrome also have decreased lifetime exposure to estrogen, a new study has determined.
Late-in-life weight gain or weight loss appears to be associated with an increased risk of dementia, shows a Korean study of 67,219 men and women between 60-79 years old.
Shared decision making should be employed in deciding on the best course of treatment for postmenopausal women with osteoporosis, experts say. In this slideshow, we highlight some of the key recommendations for diagnosing osteoporosis and assessing fracture risk in postmenopausal women.
Are blood sugar levels moving targets? Should pregnant women be screened for thyroid cancer? And, will there soon be treatment to stave off those salt and sugar cravings? Learn more about these and other developments from endocrinology research in this news recap.
Primary care providers, endocrinologists and obstetricians have been challenged with the question of whether to screen all pregnant women for thyroid disease. The debate springs primarily from unknown clinical implications of subclinical thyroid disease during pregnancy. This issue was addressed at ENDO 2019.